Syndax Pharmaceuticals (FRA:1T3) FCF Margin %: -77.62% (As of Mar. 2026)

What is Syndax Pharmaceuticals FCF Margin %?

Syndax Pharmaceuticals FRA:1T3 -0.94% 25 FCF Margin % is -77.62% as of Mar. 2026. GuruFocus rates FRA:1T3 with a GF Score™ of 25/100. The stock has 7 warning signs investors should review. Among 959 Biotechnology companies, Syndax Pharmaceuticals ranks worse than 56.1% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Syndax Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2026 was €-43.5 Mil. Syndax Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was €56.1 Mil. Therefore, Syndax Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2026 was -77.62%.

As of today, Syndax Pharmaceuticals's current FCF Yield % is -14.73%.

The historical rank and industry rank for Syndax Pharmaceuticals's FCF Margin % or its related term are showing as below:

FRA:1T3' s FCF Margin % Range Over the Past 10 Years
Min: -4697.43 Med: -2577.15 Max: 20.76
Current: -128.01

During the past 13 years, the highest FCF Margin % of Syndax Pharmaceuticals was 20.76%. The lowest was -4697.43%. And the median was -2577.15%.

FRA:1T3's FCF Margin % is ranked worse than
56.1% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs FRA:1T3: -128.01

Syndax Pharmaceuticals FCF Margin % Related Terms

Syndax Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Syndax Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syndax Pharmaceuticals FCF Margin % Chart

Syndax Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

20.76

0.00

-1,160.93

-187.50

Syndax Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Margin %	Get a 7-Day Free Trial															-474.81	-231.29	-153.77	-101.11	-77.62

FRA:1T3 vs CAPR, SLS, AGIO: FCF Margin % Comparison

For the Biotechnology subindustry, Syndax Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syndax Pharmaceuticals FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syndax Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Syndax Pharmaceuticals's FCF Margin % falls into.

Save Embed

25GF Score

Syndax Pharmaceuticals Inc FRA:1T3

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Syndax Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Syndax Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-275.985	/	147.189
	=	-187.50 %

Syndax Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-43.548	/	56.107
	=	-77.62 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -77.62% mean?

Syndax Pharmaceuticals (FRA:1T3) has a FCF Margin % of -77.62% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Syndax Pharmaceuticals and its competitors. According to the industry distribution chart, Syndax Pharmaceuticals ranks #538 out of 959 companies in the Biotechnology industry, placing it in the top 56.1%.

Is Syndax Pharmaceuticals' FCF Margin % too high?

Syndax Pharmaceuticals' current FCF Margin % is -77.62%. Based on the distribution chart, Syndax Pharmaceuticals ranks #538 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Syndax Pharmaceuticals has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.

How does Syndax Pharmaceuticals' FCF Margin % compare to CAPR and SLS?

According to the Biotechnology industry distribution chart, Syndax Pharmaceuticals ranks #538 out of 959 companies for FCF Margin %. This places Syndax Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Syndax Pharmaceuticals and its competitors. Syndax Pharmaceuticals's current FCF Margin % is -77.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Syndax Pharmaceuticals stock overvalued right now?

Syndax Pharmaceuticals (FRA:1T3) has a current FCF Margin % of -77.62%. The current FCF Margin % is -77.62%. Syndax Pharmaceuticals' overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Syndax Pharmaceuticals (FRA:1T3), the current FCF Margin % is -77.62% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Syndax Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies CAPR SLS AGIO VCEL PVLA TSHA GENB QURE ATAI NVAX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges SNDX:USA 1T3:Germany

Address 730 Third Avenue, 9th Floor, New York, NY, USA, 10017

Website https://www.syndax.com

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

25GF Score

Get the complete analysis for FRA:1T3

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.43

Price

View FRA:1T3 Analysis

See FCF Margin % data for all stocks →